Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model - Early activation and apoptosis is associated with liver graft acceptance

被引:69
作者
Sharland, A
Shastry, S
Wang, CM
Rokahr, K
Sun, JH
Sheil, AGR
McCaughan, GW
Bishop, GA
机构
[1] Royal Prince Alfred Hosp, Centenary Inst, AW Morrow Gastroenterol & Liver Lab, Camperdown, NSW 2050, Australia
[2] Univ Sydney, Dept Transplantat Surg, Sydney, NSW 2006, Australia
关键词
D O I
10.1097/00007890-199805270-00015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Liver transplants in the rat strain combination PVG-to-Dark Agouti are spontaneously tolerated, whereas kidney transplants in the same strain combination are rejected in 7-9 days. Methods. To identify organ-specific differences that might yield further information about the mechanism of tolerance induction in this strain combination, liver or kidney grafts, spleen, and draining lymph nodes were harvested at days 1, 3, 5, and 7, and examined by immunohistochemistry, terminal deoxynucleotide transferase-mediated dUTP nick end labeling assay, and reverse transcriptase-polymerase chain reaction for interferon-gamma, interleukin (IL)-2, IL-4, and IL-10. Results. Renal allograft rejection was associated with the progressive development of an intense mononuclear cell infiltrate, Markers of lymphocyte activation and cytokine up-regulation appeared from day 3, and many apoptotic parenchymal cells were noted on days 5-7, at the peak of rejection. conversely, liver allograft tolerance was associated with more rapid infiltration by activated T cells and earlier increases in cytokine expression, but with a more limited degree of cellular infiltration. Concurrent with the early activation, high levels of apoptosis were found in areas of leukocyte infiltrate, paralleling the disappearance of activated T cells from the graft between days 3 and 5. Conclusions. Apoptosis of infiltrating leukocytes in liver allografts may represent an important process in the induction of spontaneous liver transplant tolerance and may underlie the abortive nature of the effector response observed within tolerated livers. In contrast, activated cells in renal allografts in the same strain combination survive and proliferate, express high levels of cytokines, and are efficient in bringing about graft destruction.
引用
收藏
页码:1370 / 1377
页数:8
相关论文
共 68 条
[1]   Apoptosis in murine cardiac grafts [J].
Bergese, SD ;
Klenotic, SM ;
Wakely, ME ;
Sedmak, DD ;
Orosz, CG .
TRANSPLANTATION, 1997, 63 (02) :320-325
[2]  
Bishop G A, 1993, Transpl Immunol, V1, P253, DOI 10.1016/0966-3274(93)90033-5
[3]   IMMUNOPATHOLOGY OF RENAL-ALLOGRAFT REJECTION ANALYZED WITH MONOCLONAL-ANTIBODIES TO MONONUCLEAR CELL MARKERS [J].
BISHOP, GA ;
HALL, BM ;
DUGGIN, GG ;
HORVATH, JS ;
SHEIL, AGR ;
TILLER, DJ .
KIDNEY INTERNATIONAL, 1986, 29 (03) :708-717
[4]   Quantitative reverse transcriptase-PCR amplification of cytokine mRNA in liver biopsy specimens using a non-competitive method [J].
Bishop, GA ;
Rokahr, KL ;
Lowes, M ;
McGuinness, PH ;
Napoli, J ;
DeCruz, DJ ;
Wong, WY ;
McCaughan, GW .
IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (02) :142-147
[5]  
Bishop GA, 1996, J IMMUNOL, V156, P4925
[6]   High-dose/activation-associated tolerance - A mechanism for allograft tolerance [J].
Bishop, GA ;
Sun, JH ;
Sheil, AGR ;
McCaughan, GW .
TRANSPLANTATION, 1997, 64 (10) :1377-1382
[7]   IMMUNOMODULATION BY SOLUBLE HLA CLASS-I [J].
BUELOW, R ;
BURLINGHAM, WJ ;
CLAYBERGER, C .
TRANSPLANTATION, 1995, 59 (05) :649-654
[8]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[9]   PARAMETERS CONTROLLING THE PROGRAMMED DEATH OF MATURE MOUSE T-LYMPHOCYTES IN HIGH-DOSE SUPPRESSION [J].
CRITCHFIELD, JM ;
ZUNIGAPFLUCKER, JC ;
LENARDO, MJ .
CELLULAR IMMUNOLOGY, 1995, 160 (01) :71-78
[10]   CYTOKINE GENE-TRANSCRIPTION IN VASCULARIZED ORGAN GRAFTS - ANALYSIS USING SEMIQUANTITATIVE POLYMERASE CHAIN-REACTION [J].
DALLMAN, MJ ;
LARSEN, CP ;
MORRIS, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (02) :493-496